Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Maud Bagnoud"'
Autor:
Maud Bagnoud, Jana Remlinger, Marine Massy, Dmitri Lodygin, Anke Salmen, Andrew Chan, Fred Lühder, Robert Hoepner
Publikováno v:
Cells, Vol 12, Iss 18, p 2291 (2023)
Our previous work demonstrated that vitamin D (VitD) reduces experimental autoimmune encephalomyelitis (EAE) disease severity in wild-type (WT) but not in T cell-specific glucocorticoid (GC) receptor (GR)-deficient (GRlck) mice. This study aimed to i
Externí odkaz:
https://doaj.org/article/4ae99d68e0e4461abc1f44b3752bd976
Autor:
Judit Gili-Kovács, Robert Hoepner, Anke Salmen, Maud Bagnoud, Ralf Gold, Andrew Chan, Myriam Briner
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Background: Glucocorticoid (GC) pulse therapy is used for multiple sclerosis (MS) relapse treatment; however, GC resistance is a common problem. Considering that GC dosing is individual with several response-influencing factors, establishing a predic
Externí odkaz:
https://doaj.org/article/cd3538369267477a89ffae02d6f23aba
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Multiple sclerosis (MS) is characterized as an autoimmune disease affecting the central nervous system. It is one of the most common neurological disorders in young adults. Over the past decades, increasing evidence suggested that hypovitaminosis D i
Externí odkaz:
https://doaj.org/article/c96f1bbccde041a3883ed7befae56eea
Autor:
Greta Zoehner, Andrei Miclea, Anke Salmen, Nicole Kamber, Lara Diem, Christoph Friedli, Maud Bagnoud, Farhad Ahmadi, Myriam Briner, Nazanin Sédille-Mostafaie, Constantinos Kilidireas, Leonidas Stefanis, Andrew Chan, Robert Hoepner, Maria Eleftheria Evangelopoulos
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 12 (2019)
Background: In multiple sclerosis (MS), the frequency of hypogammaglobulinemia is unknown. We aimed to evaluate the frequency of reduced immunoglobulin (Ig) concentrations and its association with immunotherapy and disease course in two independent M
Externí odkaz:
https://doaj.org/article/5abc52fdfde548c4985da6fc79821dad
Autor:
Myriam Briner, Maud Bagnoud, Andrei Miclea, Christoph Friedli, Lara Diem, Andrew Chan, Robert Hoepner, Anke Salmen
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 12 (2019)
Background: Dimethyl fumarate (DMF) is licensed for treatment of relapsing–remitting multiple sclerosis (RRMS). DMF can induce lymphopenia, which is assumed to increase the risk for opportunistic infections like progressive multifocal leukoencephal
Externí odkaz:
https://doaj.org/article/9907921985a54c6b8b502cc50c04391f
Autor:
Maud Bagnoud, Myriam Briner, Jana Remlinger, Ivo Meli, Sara Schuetz, Maximilian Pistor, Anke Salmen, Andrew Chan, Robert Hoepner
Publikováno v:
Cells, Vol 9, Iss 10, p 2154 (2020)
c-Jun N-terminal kinase (JNK) is upregulated during multiple sclerosis relapses and at the peak of experimental autoimmune encephalomyelitis (EAE). We aim to investigate the effects of pharmacological pan-JNK inhibition on the course of myelin oligod
Externí odkaz:
https://doaj.org/article/f4d81d602f364a3f81c704af9ea79e11
Autor:
Jana Remlinger, Maud Bagnoud, Ivo Meli, Marine Massy, Christopher Linington, Andrew Chan, Jeffrey L. Bennett, Robert Hoepner, Volker Enzmann, Anke Salmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8953ca4238d3c295b74f32de84efbc4b
https://doi.org/10.2139/ssrn.4356442
https://doi.org/10.2139/ssrn.4356442
Autor:
Andrew T. Chan, Myriam Briner, Ralf Gold, Judit Gili-Kovács, Maud Bagnoud, Anke Salmen, Robert Hoepner
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Gili-Kovács, Judit; Hoepner, Robert; Salmen, Anke; Bagnoud, Maud; Gold, Ralf; Chan, Andrew; Briner, Myriam (2021). An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses. Therapeutic advances in neurological disorders, 14, p. 17562864211020074. Sage 10.1177/17562864211020074
Therapeutic Advances in Neurological Disorders
Gili-Kovács, Judit; Hoepner, Robert; Salmen, Anke; Bagnoud, Maud; Gold, Ralf; Chan, Andrew; Briner, Myriam (2021). An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses. Therapeutic advances in neurological disorders, 14, p. 17562864211020074. Sage 10.1177/17562864211020074
Therapeutic Advances in Neurological Disorders
Background: Glucocorticoid (GC) pulse therapy is used for multiple sclerosis (MS) relapse treatment; however, GC resistance is a common problem. Considering that GC dosing is individual with several response-influencing factors, establishing a predic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7daf9a78b5060777b2636dcfc5dba1c
https://doaj.org/article/cd3538369267477a89ffae02d6f23aba
https://doaj.org/article/cd3538369267477a89ffae02d6f23aba
Autor:
Jana Remlinger, Adrian Madarasz, Kirsten Guse, Robert Hoepner, Maud Bagnoud, Ivo Meli, Moritz Feil, Mathias Abegg, Christopher Linington, Anthony Shock, Babak Boroojerdi, Peter Kiessling, Bryan Smith, Volker Enzmann, Andrew Chan, Anke Salmen
Publikováno v:
Remlinger, Jana; Madarasz, Adrian; Guse, Kirsten; Hoepner, Robert; Bagnoud, Maud; Meli, Ivo; Feil, Moritz; Abegg, Mathias; Linington, Christopher; Shock, Anthony; Boroojerdi, Babak; Kiessling, Peter; Smith, Bryan; Enzmann, Volker; Chan, Andrew; Salmen, Anke (2022). Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune Encephalomyelitis. Neurology: neuroimmunology & neuroinflammation, 9(2) Wolters Kluwer Health 10.1212/NXI.0000000000001134
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Background and ObjectivesMyelin oligodendrocyte glycoprotein antibody–associated disorder (MOGAD) is a rare, autoimmune demyelinating CNS disorder, distinct from multiple sclerosis and neuromyelitis optica spectrum disorder. Characterized by pathog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe3c276854abc8800c06d5e79ff0046
https://doi.org/10.1212/nxi.0000000000001134
https://doi.org/10.1212/nxi.0000000000001134
Autor:
Andrew Chan, Maud Bagnoud, Seray Demir, Paul F. Worley, Farhad Ahmadi, Melissa Gresle, Holger M. Reichardt, Kirsten Guse, Lisa Schrewe, Maximilian Pistor, Helen Synn, Myriam Briner, Ralf Gold, Imke Metz, Anke Salmen, Helmut Butzkueven, Louis Laverick, Robert Hoepner, Fred Lühder
Publikováno v:
Hoepner, Robert; Bagnoud, Maud; Pistor, Maximilian; Salmen, Anke; Briner, Myriam; Synn, Helen; Schrewe, Lisa; Guse, Kirsten; Ahmadi, Farhad; Demir, Seray; Laverick, Louis; Gresle, Melissa; Worley, Paul; Reichardt, Holger Michael; Butzkueven, Helmut; Gold, Ralf; Metz, Imke; Lühder, Fred; Chan, Andrew (2019). Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta neuropathologica, 138(3), pp. 443-456. Springer-Verlag 10.1007/s00401-019-02018-8
Acta Neuropathologica
Acta Neuropathologica
The limited efficacy of glucocorticoids (GCs) during therapy of acute relapses in multiple sclerosis (MS) leads to long-term disability. We investigated the potential of vitamin D (VD) to enhance GC efficacy and the mechanisms underlying this VD/GC i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a60fed6e5a2c39aac01cced7d660fbbd